Corewell Health the Michigan Cancer Consortium

Grand Rapids, Michigan 49503-2560

1 studies enrolling now · 2 studies all time

What they study most

CLL, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling